Apr.27 — Bayer AG raised the specter of “considerable liquidity challenges” as it engages in high-stakes negotiations in the U.S. over claims that the company’s Roundup weedkiller caused cancer. Chief Executive Officer Werner Baumann discusses the challenges facing the drugmaker, and comments on the outlook for trials of its chloroquine Malaria drug as a treatment for Covid-19 patients, in an interview on “Bloomberg Markets: European Open.” …read more
Source:: Yahoo Finance
